Source: Neurotoxicity Research. Unidades: FFCLRP, FMRP
Subjects: DOENÇA DE ALZHEIMER, ESTRÓGENOS, ESTRESSE OXIDATIVO, TESTES DE TOXICIDADE
ABNT
CASTILLO, Willian Orlando et al. Genistein and galantamine combinations decrease β-amyloid peptide (1-42)-induced genotoxicity and cell death in SH-SY5Y cell line: an in vitro and in silico approach for mimic of Alzheimer’s disease. Neurotoxicity Research, v. 38, n. 3, p. 691-706, 2020Tradução . . Disponível em: https://doi.org/10.1007/s12640-020-00243-8. Acesso em: 31 out. 2024.APA
Castillo, W. O., Palomino, N. V., Takahashi, C. S., & Giuliatti, S. (2020). Genistein and galantamine combinations decrease β-amyloid peptide (1-42)-induced genotoxicity and cell death in SH-SY5Y cell line: an in vitro and in silico approach for mimic of Alzheimer’s disease. Neurotoxicity Research, 38( 3), 691-706. doi:10.1007/s12640-020-00243-8NLM
Castillo WO, Palomino NV, Takahashi CS, Giuliatti S. Genistein and galantamine combinations decrease β-amyloid peptide (1-42)-induced genotoxicity and cell death in SH-SY5Y cell line: an in vitro and in silico approach for mimic of Alzheimer’s disease [Internet]. Neurotoxicity Research. 2020 ; 38( 3): 691-706.[citado 2024 out. 31 ] Available from: https://doi.org/10.1007/s12640-020-00243-8Vancouver
Castillo WO, Palomino NV, Takahashi CS, Giuliatti S. Genistein and galantamine combinations decrease β-amyloid peptide (1-42)-induced genotoxicity and cell death in SH-SY5Y cell line: an in vitro and in silico approach for mimic of Alzheimer’s disease [Internet]. Neurotoxicity Research. 2020 ; 38( 3): 691-706.[citado 2024 out. 31 ] Available from: https://doi.org/10.1007/s12640-020-00243-8